Announced Tue, 18 Aug · 11:29 IST
Deutsche Bank releases pledge on 7.39% Piramal Pharma shares
PPLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+2.5%1-day move
₹204.50
prior close
₹209.49
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.1+0.1+0.1+0.1+2.5+6.0+4.3+3.9+1.6+5.1+10.5+1.8——
Up moveDown movePending
AI summary
Deutsche Bank AG, acting as onshore security agent for lenders, released its pledge on 98.4 million equity shares (7.39% of share capital, 7.43% of voting capital) of Piramal Pharma that were pledged by borrower CA Alchemy Investments. Release was done on 13 August 2026 to enable a permitted sale transaction under the facility agreement. After release, pledge remains on 140.26 million shares (10.54%). Deutsche Bank holds no beneficial interest in the shares.
Likely market impact
Frees up 7.39% stake held by CA Alchemy for a potential block sale. Watch for a separate sale announcement which could weigh on the stock in the near term.